Undertreatment of COPD: a retrospective analysis of US managed care and Medicare patients.

Authors:
Address: National Jewish Health, Denver, CO, USA.
Journal:

Publication:
Free Text: Undertreatment of COPD: a retrospective analysis of US managed care and Medicare patients.

abstract

BACKGROUND:

We investigated a large population of patients with chronic obstructive pulmonary disease (COPD) to determine their frequency of medication use and patterns of pharmacotherapy.

METHODS:

Medical and pharmacy claims data were retrospectively analyzed from 19 health plans (>7.79 million members) across the US. Eligible patients were aged ≥40 years, continuously enrolled during July 2004 to June 2005, and had at least one inpatient or at least two outpatient claims coded for COPD. As a surrogate for severity of illness, COPD patients were stratified by complexity of illness using predefined International Classification of Diseases, Ninth Revision, Clinical Modification, Current Procedural Terminology, Fourth Edition, and Healthcare Common Procedure Coding System codes.

RESULTS:

A total of 42,565 patients with commercial insurance and 8507 Medicare patients were identified. Their mean age was 54.7 years and 74.8 years, and 48.7% and 46.9% were male, respectively. In total, 66.3% of commercial patients (n = 28,206) were not prescribed any maintenance COPD pharmacotherapy (59.1% no medication; 7.2% inhaled short-acting β2-agonist only). In the Medicare population, 70.9% (n = 6031) were not prescribed any maintenance COPD pharmacotherapy (66.0% no medication; 4.9% short-acting β2-agonist only). A subset of patients classified as high-complexity were similarly undertreated, with 58.7% (5358/9121) of commercial and 68.8% (1616/2350) of Medicare patients not prescribed maintenance COPD pharmacotherapy. Only 18.0% and 9.8% of diagnosed smokers in the commercial and Medicare cohorts had a claim for a smoking cessation intervention and just 16.6% and 23.5%, respectively, had claims for an influenza vaccination.

CONCLUSION:

This study highlights a high degree of Undertreatment of COPD in both commercial and Medicare patients, with most patients receiving no maintenance pharmacotherapy or influenza vaccination.

Related Articles
Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.
J Manag Care Pharm. 2008
Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.
Blanchette CM, Gutierrez B, Ory C, Chang E, Akazawa M. J Manag Care Pharm. 2008 Mar; 14(2):176-85.
The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population.
Respir Med. 2008
The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population.
Menzin J, Boulanger L, Marton J, Guadagno L, Dastani H, Dirani R, Phillips A, Shah H. Respir Med. 2008 Sep; 102(9):1248-56. Epub 2008 Jul 11.
Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
Am J Geriatr Pharmacother. 2009
Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
Simoni-Wastila L, Blanchette CM, Qian J, Yang HW, Zhao L, Zuckerman IH, Pak GH, Silver H, Dalal AA. Am J Geriatr Pharmacother. 2009 Oct; 7(5):262-70.
Review Contemporary issues in the care of patients with chronic obstructive pulmonary disease.
J Manag Care Pharm. 2005
Review Contemporary issues in the care of patients with chronic obstructive pulmonary disease.
Urbano FL, Pascual RM. J Manag Care Pharm. 2005 Jun; 11(5 Suppl A):S2-13; quiz S14-6.
Review Innovations to achieve excellence in COPD diagnosis and treatment in primary care.
Postgrad Med. 2010
Review Innovations to achieve excellence in COPD diagnosis and treatment in primary care.
Fromer L, Barnes T, Garvey C, Ortiz G, Saver DF, Yawn B. Postgrad Med. 2010 Sep; 122(5):150-64.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.